Free Trial

StockNews.com Upgrades Cabot (NYSE:CBT) to "Buy"

Cabot logo with Basic Materials background
Remove Ads

StockNews.com upgraded shares of Cabot (NYSE:CBT - Free Report) from a hold rating to a buy rating in a report issued on Tuesday morning.

Other equities analysts have also issued research reports about the stock. JPMorgan Chase & Co. dropped their target price on shares of Cabot from $105.00 to $85.00 and set an "underweight" rating on the stock in a research report on Friday, February 21st. Mizuho dropped their price objective on shares of Cabot from $122.00 to $110.00 and set an "outperform" rating on the stock in a report on Tuesday, January 7th. One investment analyst has rated the stock with a sell rating, two have assigned a hold rating and two have issued a buy rating to the stock. According to MarketBeat.com, the company currently has a consensus rating of "Hold" and an average target price of $97.00.

Read Our Latest Research Report on Cabot

Cabot Stock Performance

NYSE:CBT traded down $1.45 during midday trading on Tuesday, reaching $78.39. The stock had a trading volume of 702,871 shares, compared to its average volume of 381,238. The stock has a market capitalization of $4.25 billion, a P/E ratio of 10.41, a PEG ratio of 0.74 and a beta of 1.04. Cabot has a 1-year low of $75.51 and a 1-year high of $117.46. The company has a debt-to-equity ratio of 0.72, a current ratio of 2.00 and a quick ratio of 1.29. The firm's fifty day simple moving average is $84.85 and its 200-day simple moving average is $97.38.

Remove Ads

Cabot (NYSE:CBT - Get Free Report) last issued its quarterly earnings results on Monday, February 3rd. The specialty chemicals company reported $1.76 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.74 by $0.02. Cabot had a return on equity of 26.79% and a net margin of 10.60%. On average, equities research analysts forecast that Cabot will post 7.57 EPS for the current fiscal year.

Cabot Announces Dividend

The firm also recently disclosed a quarterly dividend, which was paid on Friday, March 14th. Investors of record on Friday, February 28th were issued a $0.43 dividend. The ex-dividend date of this dividend was Friday, February 28th. This represents a $1.72 annualized dividend and a yield of 2.19%. Cabot's dividend payout ratio is currently 22.84%.

Institutional Trading of Cabot

A number of institutional investors and hedge funds have recently modified their holdings of the stock. R Squared Ltd bought a new position in shares of Cabot during the 4th quarter valued at about $26,000. EverSource Wealth Advisors LLC lifted its stake in Cabot by 37.2% in the fourth quarter. EverSource Wealth Advisors LLC now owns 808 shares of the specialty chemicals company's stock valued at $74,000 after buying an additional 219 shares in the last quarter. GAMMA Investing LLC boosted its holdings in shares of Cabot by 10.7% in the fourth quarter. GAMMA Investing LLC now owns 1,348 shares of the specialty chemicals company's stock valued at $123,000 after buying an additional 130 shares during the period. Manchester Capital Management LLC increased its position in shares of Cabot by 1,685.1% during the fourth quarter. Manchester Capital Management LLC now owns 1,678 shares of the specialty chemicals company's stock worth $153,000 after acquiring an additional 1,584 shares in the last quarter. Finally, KBC Group NV raised its holdings in shares of Cabot by 43.1% during the fourth quarter. KBC Group NV now owns 2,046 shares of the specialty chemicals company's stock worth $187,000 after acquiring an additional 616 shares during the period. 93.18% of the stock is owned by institutional investors.

About Cabot

(Get Free Report)

Cabot Corporation operates as a specialty chemicals and performance materials company. The company operates through two segments, Reinforcement Materials and Performance Chemicals. It offers reinforcing carbons that are used in tires as a rubber reinforcing agent and performance additive, as well as in industrial products, such as hoses, belts, extruded profiles, and molded goods; and engineered elastomer composites solutions.

Recommended Stories

Should You Invest $1,000 in Cabot Right Now?

Before you consider Cabot, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Cabot wasn't on the list.

While Cabot currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Reduce the Risk Cover

Market downturns give many investors pause, and for good reason. Wondering how to offset this risk? Enter your email address to learn more about using beta to protect your portfolio.

Get This Free Report
Like this article? Share it with a colleague.
Remove Ads

Featured Articles and Offers

Pelosi Bets Big on AI: Her Top 5 Stock Picks

Pelosi Bets Big on AI: Her Top 5 Stock Picks

MarketBeat's Thomas Hughes breaks down Pelosi's stock picks, her strategy, and what these moves mean for the future of the AI industry.

Recent Videos

5 International Stocks to Escape U.S. Market Volatility
MicroStrategy’s Bold Bitcoin Bet: Genius Move or Dangerous Gamble?
5 Big Reasons the S&P 500 Could Soar in 2025

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines

Remove Ads